MOSS WAY
51 MOSS WAY, LIVERPOOL
STIA007
The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record in the preceding 12 months that an anti-platelet agent, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 42 | 42 | 100.0% | |
| STROKE 9 | 2006 | 43 | 44 | 97.7% | |
| Stroke 12 | 2007 | 31 | 33 | 93.9% | |
| Stroke 12 | 2008 | 38 | 39 | 97.4% | |
| Stroke 12 | 2009 | 37 | 40 | 92.5% | |
| Stroke 12 | 2010 | 40 | 44 | 90.9% | |
| STROKE 12 | 2011 | 35 | 37 | 94.6% | |
| STROKE 12 | 2012 | 34 | 37 | 91.9% | |
| STROKE 12 | 2013 | 29 | 32 | 90.6% | |
| STIA007 | 2014 | 29 | 29 | 100.0% | |
| STIA007 | 2015 | 20 | 21 | 95.2% | |
| STIA007 | 2016 | 25 | 25 | 100.0% | |
| STIA007 | 2017 | 30 | 30 | 100.0% | |
| STIA007 | 2018 | 34 | 35 | 97.1% | |
| STIA007 | 2019 | 37 | 37 | 100.0% | |
| STIA007 | 2020 | 35 | 37 | 94.6% | |
| STIA007 | 2021 | 33 | 36 | 91.7% | |
| STIA007 | 2022 | 36 | 36 | 100.0% | |
| STIA007 | 2023 | 57 | 59 | 96.6% |
